BR9915533A - Preparações de vacina contendo toxina atenuada - Google Patents

Preparações de vacina contendo toxina atenuada

Info

Publication number
BR9915533A
BR9915533A BR9915533-8A BR9915533A BR9915533A BR 9915533 A BR9915533 A BR 9915533A BR 9915533 A BR9915533 A BR 9915533A BR 9915533 A BR9915533 A BR 9915533A
Authority
BR
Brazil
Prior art keywords
toxin
preparations containing
vaccine preparations
attenuated toxin
containing attenuated
Prior art date
Application number
BR9915533-8A
Other languages
English (en)
Inventor
Chikara Aizawa
Yuziro Suzuki
Taka-Aki Sato
Koji Watanabe
Nobuaki Hattori
Yoshitake Tanaka
Satoshi Omura
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Publication of BR9915533A publication Critical patent/BR9915533A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "PREPARAçõES DE VACINA CONTENDO TOXINA ATENUADA". Estão descritos aqui adjuvantes que contêm como o ingrediente ativo uma toxina atenuada que possui uma atividade residual de pelo menos 1/2000 da atividade da toxina natural e vacinas contendo tais adjuvantes. Pela utilização, por exemplo, da toxina do cólera natural atenuada, podem ser apresentadas vacinas capazes de exibir potencialização imunológica suficientes na vacinação percutânea ou na vacinação nasal.
BR9915533-8A 1998-10-21 1999-10-20 Preparações de vacina contendo toxina atenuada BR9915533A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30021998 1998-10-21
PCT/JP1999/005789 WO2000023107A1 (fr) 1998-10-21 1999-10-20 Preparations de vaccin contenant des toxines attenuees

Publications (1)

Publication Number Publication Date
BR9915533A true BR9915533A (pt) 2001-11-06

Family

ID=17882163

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915533-8A BR9915533A (pt) 1998-10-21 1999-10-20 Preparações de vacina contendo toxina atenuada

Country Status (9)

Country Link
EP (1) EP1123711B9 (pt)
JP (1) JP4530317B2 (pt)
KR (1) KR100649286B1 (pt)
AU (1) AU774649B2 (pt)
BR (1) BR9915533A (pt)
CA (1) CA2348658C (pt)
DE (1) DE69939943D1 (pt)
TW (1) TWI257867B (pt)
WO (1) WO2000023107A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420601A1 (en) 2000-08-31 2003-02-26 The Kitasato Institute Vaccine preparation containing fatty acid as component
EP1363663B1 (en) * 2001-01-12 2011-03-02 Novartis Vaccines and Diagnostics, Inc. Nucleic acid mucosal immunization
RU2378008C2 (ru) * 2002-05-14 2010-01-10 Новартис Вэксинес Энд Дайэгностикс С.Р.Л. Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
EP2298344B1 (en) 2008-06-04 2016-08-17 The Chemo-Sero-Therapeutic Research Institute Use of inactivated japanese encephalitis virus particle as adjuvant
JP5792240B2 (ja) * 2012-08-27 2015-10-07 武夫 西 注射シミュレータ用模擬剤及びその製造方法と製造装置
FR3031109B1 (fr) 2014-12-24 2018-08-17 Arkema France Composition de polymeres, son procede de preparation, son utilisation et composition la comprenant
JP2020043814A (ja) * 2018-09-19 2020-03-26 東ソー株式会社 無活性アルカリホスファターゼ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
DK0824358T3 (da) * 1995-05-04 2003-01-27 Aventis Pasteur Acellulære pertussisvacciner og fremgangsmåder til fremstilling deraf
GB9622660D0 (en) * 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6818222B1 (en) * 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants

Also Published As

Publication number Publication date
CA2348658C (en) 2012-01-03
CA2348658A1 (en) 2000-04-27
TWI257867B (en) 2006-07-11
EP1123711A1 (en) 2001-08-16
EP1123711B1 (en) 2008-11-19
WO2000023107A1 (fr) 2000-04-27
JP4530317B2 (ja) 2010-08-25
DE69939943D1 (de) 2009-01-02
AU6227499A (en) 2000-05-08
AU774649B2 (en) 2004-07-01
KR20010083916A (ko) 2001-09-03
EP1123711A4 (en) 2005-01-26
KR100649286B1 (ko) 2006-11-24
EP1123711B9 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
DE69942911D1 (de) Trägerprotein eines polyepitops
IE882908L (en) Novel vaccine
KR890701758A (ko) 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
NL300187I1 (nl) Acellulair vaccin.
ATE279940T1 (de) Behandlung und prävention von helicobacter- infektionen
BR9610679A (pt) Antígenos de leishmania para uso na terapia e disgnose da leishmaniose
IL173481A0 (en) Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
BR9915533A (pt) Preparações de vacina contendo toxina atenuada
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
DK0625190T3 (da) Bakterie, der forårsager fjerkræsygdom, og deraf afledt vaccine
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
张桥保 et al. Experience of Prof. Wei Jia in using acupoint fengchi
MX9708226A (es) Vacunas que contienen una saponina y un esterol.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired